The Joint Blog

APRIL 17, 2020

Reported adverse effect in many clinical trials included amnesia, impaired balance, disturbed attention, dizziness, lethargy, and somnolence. In reality, there is little evidence supporting its efficacy for many conditions however does create additional safety concerns that must be considered.

Events 48

Events THC Chronic Pain Sleep 48

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC7400098/.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

JULY 24, 2019

FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. Under those provisions, if an article (such as CBD) is an active ingredient in a drug product that has been approved under section 505 of the FD&C Act, 21 U.S.C. 331(d) and 355(a). 321(ff)(3)(B)(i) and (ii).

CBD 51

CBD Tincture Pets Chronic Pain 51

The Joint Blog

APRIL 21, 2020

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

The Cannigma

JANUARY 13, 2023

This article includes strain names as a starting point for you to find flower or products near you that match the chemical makeup, not the exact strain name. Russo concluded the evidence he examined “supports experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.”

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. A total of 117 articles were retrieved for analysis, the majority of which were news stories for a physician audience.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. dollars in thousands (except for share and per share data). . . Financial Results.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

The Cannigma

APRIL 8, 2021

We passed each other in Zoom meetings, reviewed some of my articles that I’ve written with The Cannigma. MSO: You’re a pharmacist, you’re a clinical pharmacist. CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

MAY 13, 2019

Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Data Availability: All relevant data are within the paper and its Supporting Information files. Pre-defined inclusion and exclusion criteria were applied uniformly. Copyright: © 2019 Gardiner et al.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

DECEMBER 7, 2021

“Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. She is author, co-author, and co-editor of twenty-two books, two special-edition journals, and several peer-reviewed articles.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018. Many of these are meant to address public safety risks, especially for young people. billion in 2018, and with a compound annual growth rate of 23.9%, is predicted to reach $66.3

Law 40

Law Seed-To-Sale Hemp Recreational 40